- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
Surface Oncology is a biotechnology business based in the US. Surface Oncology shares (SURF) are listed on the NASDAQ and all prices are listed in US Dollars. Surface Oncology employs 35 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Surface Oncology stock
- Trade $0 commission stocks, ETFs, and options with as little as $1
- After-hours trading available
- Earn 4.5% interest on uninvested cash with Gold
- 24/7 customer support
- $0 commission trading
- Instant withdrawals with a 1.75% fee
- Supports 250+ cryptocurrencies
- High-yield account earns up to 4.65% APY
Disclaimer: This page is not financial advice or an endorsement of digital assets, providers or services. Digital assets are volatile and risky, and past performance is no guarantee of future results. Potential regulations or policies can affect their availability and services provided. Talk with a financial professional before making a decision. Finder or the author may own cryptocurrency discussed on this page.
How to buy Surface Oncology stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SURF. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Surface Oncology stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Surface Oncology stock price (NASDAQ: SURF)
Use our graph to track the performance of SURF stocks over time.Surface Oncology shares at a glance
52-week range | $0.00 - $0.00 |
---|---|
50-day moving average | $0.95 |
200-day moving average | $0.82 |
Wall St. target price | $2.38 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.66 |
Is it a good time to buy Surface Oncology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Surface Oncology financials
Gross profit TTM | $-37,003,000 |
---|---|
Return on assets TTM | -41.42% |
Return on equity TTM | -105.78% |
Profit margin | 0% |
Book value | $0.81 |
Market Capitalization | $65.7 million |
TTM: trailing 12 months
Surface Oncology share dividends
We're not expecting Surface Oncology to pay a dividend over the next 12 months.
Surface Oncology share price volatility
Over the last 12 months, Surface Oncology's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Surface Oncology's is 1.7527. This would suggest that Surface Oncology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Surface Oncology overview
Surface Oncology, Inc. , a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 which is in phase II clinical trial targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 that is in phase 1/2 clinical trials targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited and Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114.
Frequently asked questions
What percentage of Surface Oncology is owned by insiders or institutions?Currently 7.277% of Surface Oncology shares are held by insiders and 46.033% by institutions. How many people work for Surface Oncology?
Latest data suggests 35 work at Surface Oncology. When does the fiscal year end for Surface Oncology?
Surface Oncology's fiscal year ends in December. Where is Surface Oncology based?
Surface Oncology's address is: 50 Hampshire Street, Cambridge, MA, United States, 02139 What is Surface Oncology's ISIN number?
Surface Oncology's international securities identification number is: US86877M2098 What is Surface Oncology's CUSIP number?
Surface Oncology's Committee on Uniform Securities Identification Procedures number is: 86877M209
More guides on Finder
-
Robinhood Now Let’s You Trade on the Outcome of the Presidential Election; Joining Kalshi and others.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
Robinhood Review 2024: IRA Match and No Commissions
A deep dive into the highlights and limitations of Robinhood.
Ask a question